University of California San Francisco (UCSF)

TRABECULAR SUBCHONDRAL BONE ANALYSIS OF THE DISTAL RADIUS AT ULTRA-HIGH FIELD (7T) MRI: COMPARISON WITH 3T MRI AND RADIOGRAPHY (2021) Jarraya M, Heiß R, Duryea J, Nagel AM, Lynch JA, Guermazi A, Weber MA, et al. Conference contribution HETEROGENEITY OF CARTILAGE INVOLVEMENT IN KNEES WITH RADIOGRAPHIC DISEASE SEVERITY KELLGREN-LAWRENCE 2 AND 3: THE MOST STUDY (2021) Roemer F, Felson DT, Stefanik JJ, Rabasa G, Crema MD, Wang N, Neogi T, et al. Conference contribution SUBREGIONAL ANATOMICAL PREVALENCE OF CARTILAGE DAMAGE IN KNEES WITH RADIOGRAPHIC DISEASE SEVERITY KELLGREN-LAWRENCE 2 AND 3: THE MOST STUDY (2021) Roemer F, Felson DT, Stefanik JJ, Rabasa G, Wang N, Crema M, Neogi T, et al. Conference contribution RELATION OF HIP ABDUCTOR STRENGTH TO WORSENING CARTILAGE DAMAGE IN THE KNEE: THE MULTICENTER OSTEOARTHRITIS STUDY (2021) Stefanik JJ, Felson DT, Rabasa G, Guermazi A, Römer W, Lynch J, Lewis CE, et al. Conference contribution Reactive astrocyte nomenclature, definitions, and future directions (2021) Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, et al. Journal article, Review article Reliability and change in erosion measurements by high-resolution peripheral quantitative computed tomography in a longitudinal dataset of rheumatoid arthritis patients (2021) Finzel S, Manske SL, Barnabe CC, Burghardt AJ, Marotte H, Scharmga A, Hauge EM, et al. Journal article Idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021) Munshi NC, Anderson LD, Shah N, Madduri D, Berdeja J, Lonial S, Raje N, et al. Journal article A CD22-Shp1 phosphatase axis controls integrin beta(7) display and B cell function in mucosal immunity (2021) Ballet R, Brennan M, Brandl C, Feng N, Berri J, Cheng J, Ocon B, et al. Journal article Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes (2021) Kiner E, Willie E, Schmutz H, Chandler J, Schnell A, Thakore PI, LeGros G, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution